Comparison of the Effectiveness of Face to Face Rehabilitation and Telerehabilitation in Infants With Congenital Muscular Torticollis
Launched by ISTANBUL UNIVERSITY - CERRAHPASA · Apr 25, 2025
Trial Information
Current as of July 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring two ways to help infants with Congenital Muscular Torticollis (CMT), a condition where a baby's neck muscles are tight, causing their head to tilt to one side. The study compares traditional face-to-face rehabilitation with telerehabilitation, which uses online video sessions, to see which method works better for these infants. It is open to babies aged 0-6 months who have been diagnosed with CMT, and both methods focus on improving neck movement and overall development.
Participants will be assigned to either the in-person or online therapy group, with both receiving the same care. The program includes exercises and guidance for parents to help at home over an 8-week period. Families will also gain access to a helpful online resource with information about CMT. This trial aims to provide families with flexible treatment options while contributing to future care for other children with similar conditions. If your baby meets the criteria and you are interested in participating, you can contact the research team for more information.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Infants aged 0 to 6 months
- • Diagnosed with congenital muscular torticollis (CMT)
- • Classified as Grade 1 to 3 CMT severity based on clinical assessment
- Exclusion Criteria:
- • Plagiocephaly
- • Ocular torticollis
- • Neurological complications
- • Musculoskeletal disorders of the cervical spine
- • Visual impairments
- • Hearing impairments
About Istanbul University Cerrahpasa
Istanbul University - Cerrahpasa is a prestigious academic institution renowned for its commitment to advancing medical research and education. With a focus on innovative clinical trials, the university harnesses cutting-edge methodologies to address pressing health challenges. Its collaborative environment fosters interdisciplinary research, enabling the development of effective therapeutic strategies and enhancing patient care. The institution's dedication to ethical standards and patient safety underscores its reputation as a leader in clinical research within the region and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Istanbul, , Turkey
Patients applied
Trial Officials
Nilay Arman
Study Director
Istanbul University-Cerrahpasa,Faculty of Health Sciences, Department of Physiotherapy and Rehabilitation, Division of Physiotherapy and Rehabilitation
GÖKÇEN EROL
Principal Investigator
Istanbul University-Cerrahpasa, Graduate School of Health Sciences
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported